Home>Latest
- March 29, 2022
Ministry to push legislation on climate
China has made progress on preparing a law dedicated to tackling climate change, a senior official with the Ministry of Ecology and Environment said.
- March 29, 2022
Zhenhai reports one asymptomatic COVID-19 infection
A truck driver was identified as an asymptomatic carrier of COVID-19 in Ningbo's Zhenhai district on March 28, according to local media reports.
- March 28, 2022
China sets out blueprint for fuel cell vehicles for 2025
China's top economic planner has unveiled its latest blueprint for the hydrogen sector, which is expected to push the growth of the fuel cell vehicle industry in the world's largest vehicle market.
- March 28, 2022
Zhejiang allows residents to buy antigen kits using medical insurance
Zhejiang has adjusted its medical insurance regulations in light of the latest COVID-19 outbreak, allowing its residents to temporarily pay for antigen self-test kits using their medical insurance.
- March 28, 2022
Zhejiang may drive fresh e-CNY trials
More digital renminbi trials are expected this year, including some in Zhejiang province, as part of China's efforts to build a robust ecosystem for its digital currency, experts said on Friday.
- March 28, 2022
Ningbo's attractiveness for talents remains strong
Ningbo in East China's Zhejiang was ranked 15th nationwide in terms of its attractiveness to talents in 2021, according to a report recently released by Baidu Maps
- March 28, 2022
Ningbo Zhoushan Port tops world in cargo throughput
Ningbo Zhoushan Port was ranked first in the 2021 rankings for global ports in terms of cargo throughput, according to a report recently released by the Shanghai International Shipping Institute (SISI).
- March 25, 2022
China approves Takeda cancer drug
Japanese pharmaceutical company Takeda announced on Friday that Brigatinib, an innovative lung cancer drug, has been approved by China's National Medical Products Administration, bringing a new treatment option for lung cancer patients.
